Radiopharmaceutical composition
    3.
    发明授权
    Radiopharmaceutical composition 有权
    放射性药物组成

    公开(公告)号:US08916131B2

    公开(公告)日:2014-12-23

    申请号:US12673602

    申请日:2008-08-28

    CPC classification number: A61K9/0019 A61K47/10 A61K47/26 A61K51/0453

    Abstract: The present invention relates to radiopharmaceuticals and in particular to a radiopharmaceutical composition comprising a compound of Formula (I): and polysorbate as an excipient. The radiopharmaceutical composition of the invention reduces problems encountered with prior art compositions comprising the same class of compounds. Also provided by the invention is a method for the preparation of the radiopharmaceutical composition of the invention as well as particular uses of the radiopharmaceutical composition.

    Abstract translation: 本发明涉及放射性药物,特别涉及包含式(I)的化合物和作为赋形剂的聚山梨酯的放射性药物组合物。 本发明的放射性药物组合物减少了包含同一类化合物的现有技术组合物遇到的问题。 本发明还提供了制备本发明的放射性药物组合物的方法以及放射性药物组合物的具体用途。

    RADIOPHARMACEUTICAL COMPOSITION
    4.
    发明申请
    RADIOPHARMACEUTICAL COMPOSITION 有权
    放射医学组成

    公开(公告)号:US20110008254A1

    公开(公告)日:2011-01-13

    申请号:US12673602

    申请日:2008-08-28

    CPC classification number: A61K9/0019 A61K47/10 A61K47/26 A61K51/0453

    Abstract: The present invention relates to radiopharmaceuticals and in particular to a radiopharmaceutical composition comprising a compound of Formula (I): and polysorbate as an excipient. The radiopharmaceutical composition of the invention reduces problems encountered with prior art compositions comprising the same class of compounds. Also provided by the invention is a method for the preparation of the radiopharmaceutical composition of the invention as well as particular uses of the radiopharmaceutical composition.

    Abstract translation: 本发明涉及放射性药物,特别涉及包含式(I)的化合物和作为赋形剂的聚山梨酯的放射性药物组合物。 本发明的放射性药物组合物减少了包含同一类化合物的现有技术组合物遇到的问题。 本发明还提供了制备本发明的放射性药物组合物的方法以及放射性药物组合物的具体用途。

Patent Agency Ranking